437 related articles for article (PubMed ID: 30463972)
1. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
[TBL] [Abstract][Full Text] [Related]
2. Generation of "OP7 chimera" defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice.
Dogra T; Pelz L; Boehme JD; Kuechler J; Kershaw O; Marichal-Gallardo P; Baelkner M; Hein MD; Gruber AD; Benndorf D; Genzel Y; Bruder D; Kupke SY; Reichl U
Sci Rep; 2023 Nov; 13(1):20936. PubMed ID: 38017026
[TBL] [Abstract][Full Text] [Related]
3. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
[TBL] [Abstract][Full Text] [Related]
4. Production of antiviral "OP7 chimera" defective interfering particles free of infectious virus.
Pelz L; Dogra T; Marichal-Gallardo P; Hein MD; Hemissi G; Kupke SY; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2024 Dec; 108(1):97. PubMed ID: 38229300
[TBL] [Abstract][Full Text] [Related]
5. Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture.
Rüdiger D; Pelz L; Hein MD; Kupke SY; Reichl U
PLoS Comput Biol; 2021 Sep; 17(9):e1009357. PubMed ID: 34491996
[TBL] [Abstract][Full Text] [Related]
6. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.
Hein MD; Arora P; Marichal-Gallardo P; Winkler M; Genzel Y; Pöhlmann S; Schughart K; Kupke SY; Reichl U
BMC Biol; 2021 May; 19(1):91. PubMed ID: 33941189
[TBL] [Abstract][Full Text] [Related]
7. Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity.
Bdeir N; Arora P; Gärtner S; Pöhlmann S; Winkler M
Sci Rep; 2021 Oct; 11(1):20477. PubMed ID: 34650149
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication.
Kupke SY; Ly LH; Börno ST; Ruff A; Timmermann B; Vingron M; Haas S; Reichl U
Viruses; 2020 Jan; 12(1):. PubMed ID: 31936115
[TBL] [Abstract][Full Text] [Related]
9. OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential.
Hein MD; Kollmus H; Marichal-Gallardo P; Püttker S; Benndorf D; Genzel Y; Schughart K; Kupke SY; Reichl U
Appl Microbiol Biotechnol; 2021 Jan; 105(1):129-146. PubMed ID: 33275160
[TBL] [Abstract][Full Text] [Related]
10. Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.
Laske T; Heldt FS; Hoffmann H; Frensing T; Reichl U
Virus Res; 2016 Feb; 213():90-99. PubMed ID: 26592173
[TBL] [Abstract][Full Text] [Related]
11. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
Liu G; Lu Y; Liu Q; Zhou Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
[TBL] [Abstract][Full Text] [Related]
13. A system for production of defective interfering particles in the absence of infectious influenza A virus.
Bdeir N; Arora P; Gärtner S; Hoffmann M; Reichl U; Pöhlmann S; Winkler M
PLoS One; 2019; 14(3):e0212757. PubMed ID: 30822349
[TBL] [Abstract][Full Text] [Related]
14. Generation of a purely clonal defective interfering influenza virus.
Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T
Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933
[TBL] [Abstract][Full Text] [Related]
15. Cell culture-based production of defective interfering particles for influenza antiviral therapy.
Wasik MA; Eichwald L; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2018 Feb; 102(3):1167-1177. PubMed ID: 29204901
[TBL] [Abstract][Full Text] [Related]
16. Influenza A Virus Defective Viral Genomes Are Inefficiently Packaged into Virions Relative to Wild-Type Genomic RNAs.
Alnaji FG; Reiser WK; Rivera-Cardona J; Te Velthuis AJW; Brooke CB
mBio; 2021 Dec; 12(6):e0295921. PubMed ID: 34809454
[TBL] [Abstract][Full Text] [Related]
17. Influenza viruses that require 10 genomic segments as antiviral therapeutics.
Harding AT; Haas GD; Chambers BS; Heaton NS
PLoS Pathog; 2019 Nov; 15(11):e1008098. PubMed ID: 31730644
[TBL] [Abstract][Full Text] [Related]
18. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Colocalization of Influenza Viral RNA and Rab11A Is Dependent upon Microtubule Filaments.
Nturibi E; Bhagwat AR; Coburn S; Myerburg MM; Lakdawala SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724771
[TBL] [Abstract][Full Text] [Related]
20. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
